A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and lungs of a preclinical model of a rare genetic disease known as alpha-1 ...

Precision gene editing is crucial for treating genetic diseases, as it enables targeted correction of specific mutations. A Korean research team has become the first in the world to significantly ...

A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and lungs of a preclinical model of a rare genetic disease known as alpha-1 ...

Researchers develop a personalized base-editing therapy within 6 months for a newborn with a rare genetic disease — using rapid workflow that could be customized to other patients too.

Gene-editing companies hold potential to treat and cure diseases caused by genetic variants. As the name suggests, they make changes or correct defects in the organism's DNA.

Gene editing helped a desperately ill baby thrive. Scientists say it could someday treat millions By LAURA UNGAR - AP Science Writer Jun 8, 2025 3 min to read ...

CRISPR Therapeutics AG (CRSP), a pioneer in gene editing technology with a market capitalization of $3.96 billion, stands at a critical juncture as it advances its diverse pipeline of ...

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a biotechnology company at the forefront of CRISPR/Cas9 gene editing technology, stands at a critical juncture in its development pipeline.

WATCH: How CRISPR gene editing puts scientists in the driver’s seat of evolution Colossal, on the other hand, maintains that it is in the “functional de-extinction” game.

Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

Indianapolis-based Eli Lilly announced its definitive agreement to acquire Verge, a gene-editing startup, for up to $1.3 billion at $10.50 a share -- a premium of 67.5% at last closing -- with the ...